HealthSource Tirzepatide Review: Supply Cycles & Refunds

HealthSource’s tirzepatide injection page advertises from $299 every four weeks, with Initial Supply choices including Full Dose, Starter Dose Four Weeks, Starter Dose Six Weeks and Eight Weeks. The Eight Weeks choice displays $549 every eight weeks. These are supplied-period offers, not a universal $299 calendar-month bill; confirm the selected amount and recurring interval.³

The AgelessRx review illustrates a different billing calendar: its microdosing introduction is $109, followed by $318 every two months, shown as a $159 monthly equivalent. Compare the actual charge and supplied period with HealthSource’s four-week or eight-week options; an equivalent is not the amount collected each month.⁹

Initial supply labels do not replace the prescription

The Full Dose and both starter selections each display $299 every four weeks, despite the six-week wording on one option. Ask how the initial supply and next recurring payment relate. A menu label does not establish concentration, dose, treatment duration or permission to select a regimen.³

The product describes a telehealth visit, unlimited doctor messaging, ongoing support and pharmacy delivery. It also states that recurring subscription payments are automatically refunded if the monthly reassessment is not completed. Obtain the reassessment deadline, how that refund is triggered and when it appears, rather than assuming all subscription charges or cancellation requests are refunded.³

Read the applicable financial policy before intake

The Refund & Returns page says practitioner-completed prescriptions sent to the pharmacy are nonrefundable, and separately says pharmacy-processed orders cannot be refunded. Those events can precede shipping. Subscription cancellation through account settings stops later cycles; a charge already processed remains nonrefundable and cancellation takes effect at cycle end.⁴

A separate Payment Policy, framed around promotional-voucher redemption, allows requests before shipping. It describes a full refund before intake completion, retention of $25–$45 after intake, and a full refund after clinical nonapproval. Ask whether that voucher-related agreement governs your direct tirzepatide order, and which cutoff controls when its pre-shipping wording differs from the general pharmacy-submission rule.⁵

The product’s reassessment auto-refund statement is another specific condition. It should not be expanded into a guaranteed satisfaction refund or a promise that a completed clinical evaluation always costs nothing.^3,4,5

Errors and damage require prompt reporting

The general policy asks for notice within 24 hours of receiving medication. It describes exceptions for defective, damaged or incorrect products caused by the company’s error; ordinary prescription returns are not accepted. Its 30-day unopened-item return provision applies to nonprescription items, not unused tirzepatide.⁴

Approved refunds are described as processed within five to seven business days after the applicable inspection or approval. Shipping costs are generally excluded unless HealthSource made an error. Ask which evidence, pharmacy investigation and remedy apply to the actual prescription.⁴

Confirm the clinical network and actual pharmacy

The Medical Practitioners page attributes clinical care to MD Integrations, with individual practitioners not publicly listed there. The product describes a partner 503A pharmacy, while the Prescription Policy makes general licensed-dispensing claims. These statements do not identify or verify the actual preparing/dispensing facility or clinician assigned to you.^3,6,7

Confirm location eligibility, legal medical practice, clinician, facility, formulation, supplied quantity and label instructions. Claims about network reach or a fast response are not personal approval, current credential verification or a guaranteed enrollment-to-delivery schedule.^6,7

Clinical evidence and individual care

Compounded tirzepatide is not an FDA-approved finished drug.⁸ SURMOUNT-1 and SURMOUNT-5 studied specific products and treatment protocols; they do not establish this service’s outcomes or equivalence of a compounded preparation.^1,2 Confirm the actual prescription, risks, alternatives and label instructions with the treating clinician.

Further reading

whether compounded tirzepatide is still legal in 2026 · Zepbound side effects · the gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · Elara Health and Wellness · Healthicare · best tirzepatide providers